CCL16 and hepatocellular carcinoma: By this finding, we suggest that serum CCL-16 levels might be used as a biomarker for early prediction of HCC onset; people with a high risk of HCC might be monitored by measuring the serum expression level of CCL-16 for early diagnosis.